Spark Therapeutics
Pharmaceuticals
Company Overview
Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. Its products include voretigene neparvovec, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or biallelic mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia. The companys products also comprise SPK-7001 that is in Phase 1/2 trial for choroideremia; SPK-9001, which is in Phase 1/2 trial for hemophilia B; and SPK-8011 that is in Phase 1/2 trial hemophilia A. In addition, its product candidates and development programs include SPK-FVIII program to treat hemophilia A; SPK-TPP1 program for the treatment of a form of Batten disease and Huntington's disease; RhoNova for the treatment of rhodopsin-linked autosomal dominant retinitis pigmentosa; and SPK-LHON for treating Leber heredit
Top C-suite Members of Company
Connect with key decision-makers at Spark Therapeutics. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Ciecie Sulli | Chief Executive Officer | c****i@sparktx.com | |
| Holly Brunbeck | Senior Director Chief of Staff To the Chief P | h****k@sparktx.com | |
| Arun Kejariwal | Chief Executive Officer | a****l@sparktx.com | |
| Samantha Jones | Chief Legal Officer | s****s@sparktx.com | |
| Christopher Stevens | Executive Vice President | c****s@sparktx.com | |
| Arun Kejariwal | Chief Executive Officer | a****l@sparktx.com | |
| Christopher Stevens | Executive Vice President | c****s@sparktx.com | |
| Keith Lange | Vice President Head of Intellectual Property | k****e@sparktx.com | |
| Scott Hocking | Vice President | s****g@sparktx.com | |
| Amy Sarola | Vice President | a****a@sparktx.com | |
| Brian Gallagher | Controller | b****r@sparktx.com |
Email Formats
Discover the email patterns used at Spark Therapeutics to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| firstname.lastname@company.com | john.doe@company.com | 45% |
| firstname@company.com | john@company.com | 30% |
| firstinitial.lastname@company.com | j.doe@company.com | 15% |
| firstname_lastname@company.com | john_doe@company.com | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
